More articles from Invited Perspective

You have access
Synergy Between Radiopharmaceutical Therapy and Immune Response: Deciphering the Underpinning Mechanisms for Future Actions
Elif Hindié and Ravi B. Patel

Journal of Nuclear Medicine May 1, 2025, 66 (5) 793-794; DOI: https://doi.org/10.2967/jnumed.125.269644
You have access
Gastrin-Releasing Peptide Receptor Imaging and Therapy in the Era of Personalized Medicine
Clément Morgat, Andrei Iagaru and Elif Hindié

Journal of Nuclear Medicine February 1, 2025, 66 (2) 207-208; DOI: https://doi.org/10.2967/jnumed.124.268861
You have access
Perspective on Pattern of Failure in Patients with Biochemical Recurrence After PSMA Radioguided Surgery
Roberto C. Delgado Bolton

Journal of Nuclear Medicine January 1, 2025, 66 (1) 73-74; DOI: https://doi.org/10.2967/jnumed.124.268783
You have access
Changed Regulation Enables Pragmatic Solution for Cancer Patients
Uwe Holzwarth

Journal of Nuclear Medicine December 1, 2024, 65 (12) 1850; DOI: https://doi.org/10.2967/jnumed.124.268945
You have access
The DETECT Trial: Are We on the Verge of Precision Surgery in Primary Prostate Cancer?
Tobias Maurer, Christian Thomas and Boris Hadaschik

Journal of Nuclear Medicine March 1, 2024, 65 (3) 430-431; DOI: https://doi.org/10.2967/jnumed.123.267187
You have access
Clinical Outcomes After Personalized Dosimetry for ⁹⁰Y Radioembolization of Advanced Hepatocellular Carcinoma: Defining the Role of a Device in a Pharma-Centric Landscape
Michael C. Soulen and William S. Rilling

Journal of Nuclear Medicine February 1, 2024, 65 (2) 270-271; DOI: https://doi.org/10.2967/jnumed.123.267035
You have access
Unraveling the Impact of ¹⁷⁷Lu-PSMA Radioligand Therapy on Renal Impairment: Distinguishing Causation from Correlation
Aravind S. Ravi Kumar and Michael S. Hofman

Journal of Nuclear Medicine January 1, 2024, 65 (1) 85-86; DOI: https://doi.org/10.2967/jnumed.123.266638
You have access
Sequential and Combination Therapies of ²²³RaCl₂ and Prostate-Specific Membrane Antigen Radioligand Therapy
Hossein Jadvar

Journal of Nuclear Medicine December 1, 2023, 64 (12) 1932-1933; DOI: https://doi.org/10.2967/jnumed.123.266427
You have access
Out with the Old, in with the New: Can We Bridge the Gap Between Clinical Trial Results Based on Bone Scans and the Era of Modern Prostate Cancer Imaging?
Michal Eifer, Ramin Alipour, Michael S. Hofman and Aravind S. Ravi Kumar

Journal of Nuclear Medicine November 1, 2023, 64 (11) 1748-1749; DOI: https://doi.org/10.2967/jnumed.123.266025
You have access
¹⁸F-FDG PET “Metabolic Response” to Neoadjuvant Systemic Therapy for Breast Cancer: Quo Vadis?
Geraldine Gebhart

Journal of Nuclear Medicine November 1, 2023, 64 (11) 1697-1698; DOI: https://doi.org/10.2967/jnumed.123.266303

Main menu

User menu

Search

More articles from Invited Perspective

Pages